Lensar (LNSR) Capital Expenditures Growth (3y) (2022 - 2025)
Lensar (LNSR) Capital Expenditures Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 9.52% |
| 10 | Lensar | 106.25 Mn | 92.68 Mn | 9.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 97.47% |
| Mar 31, 2025 | -49.29% |
| Dec 31, 2024 | -73.21% |
| Sep 30, 2024 | -48.57% |
| Jun 30, 2024 | 34.42% |
| Mar 31, 2024 | -2.40% |
| Dec 31, 2023 | -24.61% |
| Sep 30, 2023 | -30.66% |
| Jun 30, 2023 | 5.99% |
| Mar 31, 2023 | -57.33% |
| Dec 31, 2022 | -7.06% |